Show simple item record

Treatment of the pregnant mother with cancer: A systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors

dc.contributor.authorAzim, Hatem A.en
dc.contributor.authorPavlidis, Nicholasen
dc.contributor.authorPeccatori, Fedro A.en
dc.creatorAzim, Hatem A.en
dc.creatorPavlidis, Nicholasen
dc.creatorPeccatori, Fedro A.en
dc.date.accessioned2018-06-22T09:52:26Z
dc.date.available2018-06-22T09:52:26Z
dc.date.issued2010
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/41355
dc.description.abstractManaging pregnant patients with hematological tumors pose even more conflicts compared to solid tumors. Unlike the majority of solid tumors, hematological malignancies are potentially curable; hence it is important to deliver the best treatment options available, which sometimes could be too aggressive to deliver during pregnancy.In part II, we report the results of women with hematological malignancies treated with systemic therapies during the course of pregnancy. Lymphoma, acute leukemia and chronic myeloid leukemia were the most commonly treated.We discuss the safety of the different regimens reported and propose alternatives to standardized approaches in case they pose significant risk to the pregnancy and/or the fetus. © 2009 Elsevier Ltd.en
dc.language.isoengen
dc.sourceCancer treatment reviewsen
dc.subjectMethodologyen
dc.subjectAntineoplastic agenten
dc.subjectAntineoplastic agentsen
dc.subjectAsparaginaseen
dc.subjectBleomycinen
dc.subjectChlormethineen
dc.subjectCyclophosphamideen
dc.subjectCytarabineen
dc.subjectDacarbazineen
dc.subjectDaunorubicinen
dc.subjectDoxorubicinen
dc.subjectHumanen
dc.subjectHydroxyureaen
dc.subjectMethotrexateen
dc.subjectPrednisoneen
dc.subjectProcarbazineen
dc.subjectVinblastineen
dc.subjectVincristineen
dc.subjectHumansen
dc.subjectFemaleen
dc.subjectCancer combination chemotherapyen
dc.subjectChemotherapyen
dc.subjectDrug efficacyen
dc.subjectDrug safetyen
dc.subjectLeukopeniaen
dc.subjectGranulocyte colony stimulating factoren
dc.subjectTreatment outcomeen
dc.subjectReviewen
dc.subjectNeoplasticen
dc.subjectPregnancy complicationsen
dc.subjectPregnancy outcomeen
dc.subjectSafetyen
dc.subjectPregnancyen
dc.subjectAcute granulocytic leukemiaen
dc.subjectAcute lymphoblastic leukemiaen
dc.subjectAlpha interferonen
dc.subjectAntibiotic agenten
dc.subjectB cell lymphomaen
dc.subjectBlood diseaseen
dc.subjectBurkitt lymphomaen
dc.subjectBusulfanen
dc.subjectCancer radiotherapyen
dc.subjectCardiomyopathyen
dc.subjectChronic myeloid leukemiaen
dc.subjectCleft lipen
dc.subjectCleft palateen
dc.subjectCongenital malformationen
dc.subjectDisseminated intravascular clottingen
dc.subjectDose responseen
dc.subjectDose-response relationshipen
dc.subjectDown syndromeen
dc.subjectDrugen
dc.subjectEmbryopathyen
dc.subjectEnterocolitisen
dc.subjectEnvironmental exposureen
dc.subjectFetus deathen
dc.subjectFetus distressen
dc.subjectGastroenteritisen
dc.subjectGrowth retardationen
dc.subjectHeart atrium septum defecten
dc.subjectHematologic malignancyen
dc.subjectHematologic neoplasmsen
dc.subjectHemolytic anemiaen
dc.subjectHodgkin diseaseen
dc.subjectHuman immunodeficiency virus infectionen
dc.subjectHydrocephalusen
dc.subjectHypospadiasen
dc.subjectIdarubicinen
dc.subjectImatiniben
dc.subjectImmunosuppressive agenten
dc.subjectImmunosuppressive agentsen
dc.subjectImmunotherapyen
dc.subjectJaundiceen
dc.subjectLamivudineen
dc.subjectLeukemia in pregnancyen
dc.subjectLymphoma in pregnancyen
dc.subjectMelphalanen
dc.subjectMeningoceleen
dc.subjectMercaptopurineen
dc.subjectMitoxantroneen
dc.subjectNonhodgkin lymphomaen
dc.subjectPancytopeniaen
dc.subjectPolydactylyen
dc.subjectPregnancy complicationen
dc.subjectPromyelocytic leukemiaen
dc.subjectPylorus stenosisen
dc.subjectRetinoic aciden
dc.subjectRituximaben
dc.subjectSpontaneous abortionen
dc.subjectSystematic reviewen
dc.subjectTeratogenicityen
dc.subjectThumb malformationen
dc.subjectTioguanineen
dc.subjectUmbilical herniaen
dc.subjectUnindexed drugen
dc.subjectWarfarinen
dc.subjectZidovudineen
dc.titleTreatment of the pregnant mother with cancer: A systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumorsen
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.ctrv.2009.11.004
dc.description.volume36
dc.description.issue2
dc.description.startingpage110
dc.description.endingpage121
dc.author.facultyΙατρική Σχολή / Medical School
dc.author.departmentΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen
dc.contributor.orcidPavlidis, Nicholas [0000-0002-2195-9961]
dc.contributor.orcidPeccatori, Fedro A. [0000-0001-8227-8740]
dc.contributor.orcidAzim, Hatem A. [0000-0003-4344-777X]
dc.gnosis.orcid0000-0002-2195-9961
dc.gnosis.orcid0000-0001-8227-8740
dc.gnosis.orcid0000-0003-4344-777X


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record